MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies
RESEARCH|Updated:2025-12-13
|
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies
“In the field of liver cancer treatment, researchers have made significant progress. They found that radiofrequency ablation (RFA) treatment upregulated MELK expression, and MELK inhibition promoted RFA efficacy by immunogenic cell death and the antitumor response. Targeting MELK via RGD-LNPs provides new insight into improving RFA efficacy in HCC clinical treatment and combating the malignant progression of liver cancer.”
Military Medical ResearchVol. 12, Issue 7, Pages: 1046-1064(2025)
Affiliations:
1.Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Lishui Hospital, School of Medicine, Zhejiang University, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, Zhejiang, China
2.Institute of Imaging Diagnosis and Minimally Invasive Intervention Research, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, Zhejiang, China
3.Department of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China
4.Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China
5.Clinical College of the Affiliated Central Hospital, School of Medicine, Lishui University, Lishui 323000, Zhejiang, China
Cite this article as: Tang BF, Xu WT, Fang SJ, Zhu JY, Qiu RF, Shen L, et al. MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. Mil Med Res. 2025;12(1):5.
DOI:
Cite this article as: Tang BF, Xu WT, Fang SJ, Zhu JY, Qiu RF, Shen L, et al. MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. Mil Med Res. 2025;12(1):5. DOI: 10.1186/s40779-024-00588-7.
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies
Role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity
mRNA vaccine development for cholangiocarcinoma: a precise pipeline
New Calculation Method of Water Inflow Quantity in Wulong Tunnel on Chongqing--Huaihua Railway
Research on Reinforcement Technique to Enhance Lateral Stiffness of Steel Truss Bridge on Existing Railway
Analysis on the Reason of Larger Wheel/Rail Lateral Force for Loaded Car with 3D-axle Welded-frame Bogies during Negotiating
Related Author
Guo-Hui Liu
Yuan Xiong
Bo-Bin Mi
Ze Lin
Yi-Qiang Hu
Le Yu
Kang-Kang Zha
Adriana C. Panayi
Related Institution
Harvard Stem Cell Institute, Harvard University
Skeletal Biology Laboratory, Department of Orthopedic Surgery, Brigham and Women’s Hospital, Harvard Medical School
Joint Laboratory of Optofluidic Technology and System, National Center for International Research on Green Optoelectronics, South China Academy of Advanced Optoelectronics, South China Normal University
Department of Physics, Center for Hybrid Nanostructure (CHyN), University of Hamburg
Department of Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine